Compare Humana Inc (HUM) vs Shell PLC (SHEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Shell PLC — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while Shell PLC trades at $99.72 (market cap $275.54B). The key difference: Shell PLC is far larger — about 5.8× Humana Inc's market cap, and Shell PLC pays the higher dividend (3.23%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Shell PLC for 90 Days on average.
| HUM | SHEL | |
|---|---|---|
Market Cap | $47.61B | $275.54B |
Volume | 1,827,332 | 4,925,662 |
Sector | Health | Energy |
52-Week High | $409.85 | $100.20 |
52-Week Low | $163.67 | $70.31 |
Typical Hold Time | 53 Days | 90 Days |
Enterprise Value | $54.97B | $317.24B |
Dividend Yield | 0.89% | 3.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
Shell (SHEL) trades at $100.20, up 2.64% today, approaching its 52-week high with strong technical momentum. The stock shows solid fundamentals with a P/E of 10.71 and net income margin of 8.76%, supported by recent earnings beats. Recent developments include the LNG Canada Phase 2 expansion approval, doubling export capacity to 28 million metric tons annually, positioning Shell for long-term growth in global LNG markets.
Outlook remains positive with analyst consensus at Buy (61.5%) and $102.53 price target. Key opportunities include LNG expansion and portfolio optimization, while risks involve energy price volatility and execution of major projects. The current valuation appears reasonable given strong cash flow generation and strategic positioning in transitional energy markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →
